{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:53:27Z","timestamp":1785549207154,"version":"3.56.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95439-3","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:06:03Z","timestamp":1751425563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring possible hub genes of metabolic syndrome and type 2 diabetes mellitus: a systematic network biology study"],"prefix":"10.1038","volume":"15","author":[{"given":"Ashish","family":"Runthala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa R.","family":"Vulichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreya","family":"Kosanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwari","family":"Pasupula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakarla","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monoj","family":"Sutradhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar Pranav","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"95439_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","volume":"68","author":"JJ Heindel","year":"2017","unstructured":"Heindel, J. J. et al. Vandenberg, L. N. Metabolism disrupting chemicals and metabolic disorders. Reprod. Toxicol. 68, 3\u201333 (2017).","journal-title":"Reprod. Toxicol."},{"key":"95439_CR2","doi-asserted-by":"publisher","first-page":"109924","DOI":"10.1016\/j.diabres.2022.109924","volume":"188","author":"JJ Noubiap","year":"2022","unstructured":"Noubiap, J. J. et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res. Clin. Pract. 188, 109924 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"95439_CR3","doi-asserted-by":"publisher","first-page":"10672","DOI":"10.3390\/ijms241310672","volume":"24","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez, V. J. et al. New insights and potential therapeutic interventions in metabolic diseases. Int. J. Mol. Sci. 24, 10672 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"95439_CR4","doi-asserted-by":"publisher","first-page":"554961","DOI":"10.3389\/fphar.2020.554961","volume":"11","author":"FF Lillich","year":"2021","unstructured":"Lillich, F. F., Imig, J. D. & Proschak, E. Multi-target approaches in metabolic syndrome. Front. Pharmacol. 11, 554961 (2021).","journal-title":"Front. Pharmacol."},{"key":"95439_CR5","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"G M Reaven","year":"1988","unstructured":"M. Reaven, G. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37, 1595\u20131607 (1988).","journal-title":"Diabetes"},{"key":"95439_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen, M. G. The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep. 20, 1\u20138 (2018).","journal-title":"Curr. Hypertens. Rep."},{"key":"95439_CR7","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed, G. et al. I. Metabolic syndrome: updates on pathophysiology and management in 2021. Int. J. Mol. Sci. 23, 786 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"95439_CR8","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120, 1640\u20131645 (2009).","journal-title":"Circulation"},{"key":"95439_CR9","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/nu13062102","volume":"13","author":"ME Zujko","year":"2021","unstructured":"Zujko, M. E., Ro\u017cniata, M. & Zujko, K. Individual diet modification reduces the metabolic syndrome in patients before Pharmacological treatment. Nutrients 13, 2102 (2021).","journal-title":"Nutrients"},{"key":"95439_CR10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","volume":"109","author":"SM Grundy","year":"2004","unstructured":"Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C. & Lenfant, C. Definition of metabolic syndrome: report of the National heart, lung, and blood institute\/american heart association conference on scientific issues related to definition. Circulation 109, 433\u2013438 (2004).","journal-title":"Circulation"},{"key":"95439_CR11","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KGM Alberti","year":"2005","unstructured":"Alberti, K. G. M., Zimmet, P. & Shaw, J. The metabolic syndrome\u2014a new worldwide definition. Lancet 366, 1059\u20131062 (2005).","journal-title":"Lancet"},{"key":"95439_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrd2005","volume":"5","author":"SM Grundy","year":"2006","unstructured":"Grundy, S. M. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat. Rev. Drug Discov. 5, 295\u2013309 (2006).","journal-title":"Nat. Rev. Drug Discov"},{"key":"95439_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/medicina59101711","volume":"59","author":"M Rus","year":"2023","unstructured":"Rus, M. et al. Prevalence and risk factors of metabolic syndrome: A prospective study on cardiovascular health. Medicina 59, 1711 (2023).","journal-title":"Medicina"},{"key":"95439_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-2-4","volume":"2","author":"A Tenenbaum","year":"2003","unstructured":"Tenenbaum, A., Fisman, E. Z. & Motro, M. Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovasc. Diabetol. 2, 1\u20137 (2003).","journal-title":"Cardiovasc. Diabetol."},{"key":"95439_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/diabetology4020015","volume":"4","author":"BK Jha","year":"2023","unstructured":"Jha, B. K. et al. Progress in Understanding metabolic syndrome and knowledge of its complex pathophysiology. Diabetology 4, 134\u2013159 (2023).","journal-title":"Diabetology"},{"key":"95439_CR16","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/01.CIR.0000158483.13093.9D","volume":"111","author":"P Dandona","year":"2005","unstructured":"Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P. & Garg, R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448\u20131454 (2005).","journal-title":"Circulation"},{"key":"95439_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","volume":"105","author":"N Esser","year":"2014","unstructured":"Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J. & Paquot, N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 105, 141\u2013150 (2014).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"95439_CR18","doi-asserted-by":"publisher","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","volume":"14","author":"X Zhao","year":"2023","unstructured":"Zhao, X. et al. The crucial role and mechanism of insulin resistance in metabolic disease. Front. Endocrinol. 14, 1149239 (2023).","journal-title":"Front. Endocrinol."},{"key":"95439_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor, M. F. & Hotamisligil, G. S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415\u2013445 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"95439_CR20","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.3390\/cells11193001","volume":"11","author":"H Li","year":"2022","unstructured":"Li, H. et al. Macrophages, chronic inflammation, and insulin resistance. Cells 11, 3001 (2022).","journal-title":"Cells"},{"key":"95439_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm, T. V., Meier, D. T., Olefsky, J. M. & Donath, M. Y. Inflammation in obesity, diabetes, and related disorders. Immunity 55, 31\u201355 (2022).","journal-title":"Immunity"},{"key":"95439_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cmet.2007.07.006","volume":"6","author":"IF Charo","year":"2007","unstructured":"Charo, I. F. Macrophage polarization and insulin resistance: PPAR\u03b3 in control. Cell. Metab. 6, 96\u201398 (2007).","journal-title":"Cell. Metab."},{"key":"95439_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI29881","volume":"117","author":"CN Lumeng","year":"2007","unstructured":"Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175\u2013183 (2007).","journal-title":"J. Clin. Invest."},{"key":"95439_CR24","doi-asserted-by":"crossref","unstructured":"Subramanian, V., Ferrante, A. W. & Obesity Inflammation, and Macrophages. In Emerging Societies-Coexistence of Childhood Malnutrition and Obesity 63, 259\u2013268Karger, Switzerland, (2009).","DOI":"10.1159\/000209979"},{"key":"95439_CR25","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nature04634","volume":"440","author":"N Houstis","year":"2006","unstructured":"Houstis, N., Rosen, E. D. & Lander, E. S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944\u2013948 (2006).","journal-title":"Nature"},{"key":"95439_CR26","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nri2449","volume":"8","author":"GS Hotamisligil","year":"2008","unstructured":"Hotamisligil, G. S. & Erbay, E. Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 8, 923\u2013934 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"95439_CR27","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1128\/MCB.00192-09","volume":"29","author":"N Halberg","year":"2009","unstructured":"Halberg, N. et al. Hypoxia-inducible factor 1\u03b1 induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell. Biol. 29, 4467\u20134483 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"95439_CR28","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2014.05.012","volume":"157","author":"YS Lee","year":"2014","unstructured":"Lee, Y. S. et al. Increased adipocyte O2 consumption triggers HIF-1\u03b1, causing inflammation and insulin resistance in obesity. Cell 157, 1339\u20131352 (2014).","journal-title":"Cell"},{"key":"95439_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel, A. R. & Olefsky, J. M. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Invest. 127, 1\u20134 (2017).","journal-title":"J. Clin. Invest."},{"key":"95439_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1079\/BJN20041213","volume":"92","author":"P Trayhurn","year":"2004","unstructured":"Trayhurn, P. & Wood, I. S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 92, 347\u2013355 (2004).","journal-title":"Br. J. Nutr."},{"key":"95439_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s43044-023-00352-7","volume":"75","author":"PK Roy","year":"2023","unstructured":"Roy, P. K., Islam, J. & Lalhlenmawia, H. Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance. Egypt. Heart J. 75, 24 (2023).","journal-title":"Egypt. Heart J."},{"key":"95439_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2012","volume":"93","author":"P Trayhurn","year":"2013","unstructured":"Trayhurn, P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol. Rev. 93, 1\u201321 (2013).","journal-title":"Physiol. Rev."},{"key":"95439_CR33","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu, H. & Ballantyne, C. M. Metabolic inflammation and insulin resistance in obesity. Circ. Res. 126, 1549\u20131564 (2020).","journal-title":"Circ. Res."},{"key":"95439_CR34","first-page":"182","volume":"11","author":"K Fatima","year":"2021","unstructured":"Fatima, K., Hussain, Z. & Hamid, R. Oxidative stress and diabetic complication: A systematic review. Chem. Biol. Interface. 11, 182 (2021).","journal-title":"Chem. Biol. Interface"},{"key":"95439_CR35","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","volume":"132","author":"SE Shoelson","year":"2007","unstructured":"Shoelson, S. E., Herrero, L. & Naaz, A. Obesity, inflammation, and insulin resistance. Gastroenterology 132, 2169\u20132180 (2007).","journal-title":"Gastroenterology"},{"key":"95439_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky, J. M. & Glass, C. K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219\u2013246 (2010).","journal-title":"Annu. Rev. Physiol."},{"key":"95439_CR37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","volume":"6","author":"I Hameed","year":"2015","unstructured":"Hameed, I. et al. Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition. World J. Diabetes. 6, 598 (2015).","journal-title":"World J. Diabetes"},{"key":"95439_CR38","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.3390\/ijms22147644","volume":"22","author":"L Dilworth","year":"2021","unstructured":"Dilworth, L., Facey, A. & Omoruyi, F. Diabetes mellitus and its metabolic complications: the role of adipose tissues. Int. J. Mol. Sci. 22, 7644 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"95439_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/medicina59030561","volume":"59","author":"MR Hayden","year":"2023","unstructured":"Hayden, M. R. Overview and new insights into the metabolic syndrome: risk factors and emerging variables in the development of type 2 diabetes and cerebrocardiovascular disease. Medicina 59, 561 (2023).","journal-title":"Medicina"},{"key":"95439_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1586\/14779072.5.3.491","volume":"5","author":"C Bianchi","year":"2007","unstructured":"Bianchi, C., Penno, G., Romero, F., Del Prato, S. & Miccoli, R. Treating the metabolic syndrome. Expert Rev. Cardiovasc. Ther. 5, 491\u2013506 (2007).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"95439_CR41","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00592-015-0819-8","volume":"53","author":"M Noale","year":"2016","unstructured":"Noale, M. et al. Reply to letter to the editor polypharmacy in elderly people with diabetes admitted to hospital. Acta Diabetol. 53, 859\u2013860 (2016).","journal-title":"Acta Diabetol."},{"key":"95439_CR42","doi-asserted-by":"publisher","first-page":"e020852","DOI":"10.1136\/bmjopen-2017-020852","volume":"8","author":"M Alwhaibi","year":"2018","unstructured":"Alwhaibi, M. et al. Polypharmacy among patients with diabetes: A cross-sectional retrospective study in a tertiary hospital in Saudi Arabia. BMJ Open. 8, e020852 (2018).","journal-title":"BMJ Open."},{"key":"95439_CR43","first-page":"27","volume":"9","author":"V Kothari","year":"2016","unstructured":"Kothari, V., Galdo, J. A. & Mathews, S. T. Hypoglycemic agents and potential anti-inflammatory activity. J. Inflamm. Res. 9, 27\u201338 (2016).","journal-title":"J. Inflamm. Res."},{"key":"95439_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/ph14020122","volume":"14","author":"J Drzewoski","year":"2021","unstructured":"Drzewoski, J. & Hanefeld, M. The current and potential therapeutic use of metformin\u2014the good old drug. Pharmaceuticals 14, 122 (2021).","journal-title":"Pharmaceuticals"},{"key":"95439_CR45","doi-asserted-by":"publisher","first-page":"111416","DOI":"10.1016\/j.mehy.2024.111416","volume":"189","author":"M Ott","year":"2024","unstructured":"Ott, M. & Werneke, U. Metformin-associated lactic acidosis May be treatable with thiamine. Med. Hypotheses. 189, 111416 (2024).","journal-title":"Med. Hypotheses"},{"key":"95439_CR46","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3390\/ph15070810","volume":"15","author":"I Szymczak-Pajor","year":"2022","unstructured":"Szymczak-Pajor, I., Wenclewska, S. & \u015aliwi\u0144ska, A. Metabolic action of Metformin. Pharmaceuticals 15, 810 (2022).","journal-title":"Pharmaceuticals"},{"key":"95439_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","volume":"19","author":"M Foretz","year":"2023","unstructured":"Foretz, M., Guigas, B., Viollet, B. & Metformin Update on mechanisms of action and repurposing potential. Nat. Rev. Endocrinol. 19, 460\u2013476 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"95439_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv, Z. & Guo, Y. Metformin and its benefits for various diseases. Front. Endocrinol. 11, 191 (2020).","journal-title":"Front. Endocrinol."},{"key":"95439_CR49","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3390\/ijms22052596","volume":"22","author":"H Kaneto","year":"2021","unstructured":"Kaneto, H., Kimura, T., Obata, A., Shimoda, M. & Kaku, K. Multifaceted mechanisms of action of Metformin which have been unraveled one after another in the long history. Int. J. Mol. Sci. 22, 2596 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"95439_CR50","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk, D. et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 49, D605\u2013D612 (2021).","journal-title":"Nucleic Acids Res."},{"key":"95439_CR51","doi-asserted-by":"publisher","first-page":"D36","DOI":"10.1093\/nar\/gku1055","volume":"43","author":"GR Brown","year":"2015","unstructured":"Brown, G. R. et al. A gene-centered information resource at NCBI. Nucleic Acids Res. 43, D36\u201342 (2015).","journal-title":"Nucleic Acids Res."},{"key":"95439_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2440","volume":"216","author":"F Pont\u00e9n","year":"2008","unstructured":"Pont\u00e9n, F., Jirstr\u00f6m, K. & Uhlen, M. The human protein Atlas\u2014a tool for pathology. J. Pathol. 216, 387\u2013393 (2008).","journal-title":"J. Pathol."},{"key":"95439_CR53","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. D\u2019Eustachio, P. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013678 (2024).","journal-title":"Nucleic Acids Res."},{"key":"95439_CR54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-60761-987-1_18","volume":"696","author":"M Kohl","year":"2011","unstructured":"Kohl, M., Wiese, S., Warscheid, B. & Cytoscape Software for visualization and analysis of biological networks. Methods Mol. Biol. 696, 291\u2013303 (2011).","journal-title":"Methods Mol. Biol."},{"key":"95439_CR55","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12010-022-04111-3","volume":"195","author":"S Shreya","year":"2023","unstructured":"Shreya, S. et al. Tracing the anti-cancer mechanism of Pleurotus osteratus by the integrative approach of network Pharmacology and experimental studies. Appl. Biochem. Biotechnol. 195, 152\u2013171 (2023).","journal-title":"Appl. Biochem. Biotechnol."},{"key":"95439_CR56","doi-asserted-by":"publisher","first-page":"W193","DOI":"10.1093\/nar\/gkm226","volume":"35","author":"J Reimand","year":"2007","unstructured":"Reimand, J., Kull, M., Peterson, H., Hansen, J. & Vilo, J. g:Profiler\u2013a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 35, W193\u2013200 (2007).","journal-title":"Nucleic Acids Res."},{"key":"95439_CR57","doi-asserted-by":"publisher","first-page":"W171","DOI":"10.1093\/nar\/gky458","volume":"46","author":"DJB Clarke","year":"2018","unstructured":"Clarke, D. J. B. et al. Ma\u2019ayan, A. eXpression2Kinases (X2K) web: linking expression signatures to upstream cell signaling networks. Nucleic Acids Res. 46, W171\u2013W179 (2018).","journal-title":"Nucleic Acids Res."},{"key":"95439_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. K. E. G. G. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"95439_CR59","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"95439_CR60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian, M., Suh, J. M. & Hsiao, J. J. PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat. Med. 19, 557\u2013566 (2013).","journal-title":"Nat. Med."},{"key":"95439_CR61","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/jcsm.13251","volume":"14","author":"K Ghaibour","year":"2023","unstructured":"Ghaibour, K. et al. Androgen receptor coordinates muscle metabolic and contractile functions. J. Cachexia Sarcopenia Muscle. 14, 1707\u20131720 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"95439_CR62","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/med.21878","volume":"42","author":"S Kaimala","year":"2022","unstructured":"Kaimala, S., Kumar, C. A., Allouh, M. Z., Ansari, S. A. & Emerald, B. S. Epigenetic modifications in pancreas development, diabetes, and therapeutics. Med. Res. Rev. 42, 1343\u20131371 (2022).","journal-title":"Med. Res. Rev."},{"key":"95439_CR63","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cmet.2016.07.001","volume":"24","author":"T Papagiannakopoulos","year":"2016","unstructured":"Papagiannakopoulos, T. et al. Circadian rhythm disruption promotes lung tumorigenesis. Cell. Metab. 24, 324\u2013331 (2016).","journal-title":"Cell. Metab."},{"key":"95439_CR64","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1017\/erm.2024.13","volume":"26","author":"B Morone","year":"2024","unstructured":"Morone, B. & Grimaldi, G. PARP enzymes and mono-ADP-ribosylation: advancing the connection from interferon-signalling to cancer biology. Exp. Rev. Mol. Med. 26, e17 (2024).","journal-title":"Exp. Rev. Mol. Med."},{"key":"95439_CR65","doi-asserted-by":"publisher","first-page":"115067","DOI":"10.1016\/j.biopha.2023.115067","volume":"165","author":"H Zhao","year":"2023","unstructured":"Zhao, H. et al. The regulation of circrna and LncRNA protein binding in cardiovascular diseases: emerging therapeutic targets. Biomed. Pharmacother. 165, 115067 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"95439_CR66","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3390\/cells13151244","volume":"13","author":"S Dalle","year":"2024","unstructured":"Dalle, S. & Abderrahmani, A. Receptors and signaling pathways controlling beta-cell function and survival as targets for anti-diabetic therapeutic strategies. Cells 13, 1244 (2024).","journal-title":"Cells"},{"key":"95439_CR67","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/biomedicines10010103","volume":"10","author":"I Szczerbinska","year":"2022","unstructured":"Szczerbinska, I. et al. Large-scale functional genomics screen to identify modulators of human \u03b2-cell insulin secretion. Biomedicines 10, 103 (2022).","journal-title":"Biomedicines"},{"key":"95439_CR68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.tem.2023.01.001","volume":"34","author":"J Bar-Tana","year":"2023","unstructured":"Bar-Tana, J. mTORC1 syndrome (TorS): unified paradigm for diabetes\/metabolic syndrome. Trends Endocrinol. Metab. 34, 135\u2013145 (2023).","journal-title":"Trends Endocrinol. Metab."},{"key":"95439_CR69","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.chembiol.2018.03.008","volume":"25","author":"KR Ngoei","year":"2018","unstructured":"Ngoei, K. R. et al. Structural determinants for small-molecule activation of skeletal muscle AMPK \u03912\u03b22\u03b31 by the glucose importagog SC4. Cell. Chem. Biol. 25, 728\u2013737e9 (2018).","journal-title":"Cell. Chem. Biol."},{"key":"95439_CR70","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/ph17070847","volume":"17","author":"J Kowalska","year":"2024","unstructured":"Kowalska, J. & Wrze\u015bniok, D. Skin-related adverse reactions induced by oral antidiabetic drugs\u2014A review of literature and case reports. Pharmaceuticals 17, 847 (2024).","journal-title":"Pharmaceuticals"},{"key":"95439_CR71","doi-asserted-by":"publisher","first-page":"204201882098022","DOI":"10.1177\/2042018820980225","volume":"13","author":"C Baker","year":"2021","unstructured":"Baker, C. et al. Should Metformin remain the first-line therapy for treatment of type 2 diabetes? Ther. Adv. Endocrinol. Metab. 13, 2042018820980225 (2021).","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"95439_CR72","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"A Hopkins","year":"2008","unstructured":"Hopkins, A. Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4, 682\u2013690 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"95439_CR73","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/molecules27020334","volume":"27","author":"JE Kim","year":"2022","unstructured":"Kim, J. E. et al. The roles and associated mechanisms of adipokines in development of metabolic syndrome. Molecules 27, 334 (2022).","journal-title":"Molecules"},{"key":"95439_CR74","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3389\/fendo.2018.00748","volume":"9","author":"S Zhou","year":"2018","unstructured":"Zhou, S., Tang, X. & Chen, H. Z. Sirtuins and insulin resistance. Front. Endocrinol. 9, 748 (2018).","journal-title":"Front. Endocrinol."},{"key":"95439_CR75","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41231-019-0034-7","volume":"4","author":"A Kanwal","year":"2019","unstructured":"Kanwal, A. & Dsouza, L. A. Sirtuins and diabetes: optimizing the sweetness in the blood. Transl Med. Commun. 4, 3 (2019).","journal-title":"Transl Med. Commun."},{"key":"95439_CR76","doi-asserted-by":"publisher","first-page":"E581","DOI":"10.1152\/ajpendo.90437.2008","volume":"296","author":"S Boura-Halfon","year":"2009","unstructured":"Boura-Halfon, S. & Zick, Y. Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 296, E581\u2013E591 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"95439_CR77","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li, M. et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal. Transduct. Target. Ther. 7, 216 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"95439_CR78","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nature01667","volume":"423","author":"P Puigserver","year":"2003","unstructured":"Puigserver, P. et al. Insulin-regulated hepatic gluconeogenesis through FOXO1\u2013PGC-1\u03b1 interaction. Nature 423, 550\u2013555 (2003).","journal-title":"Nature"},{"key":"95439_CR79","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976 (2017).","journal-title":"Cell"},{"key":"95439_CR80","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fendo.2018.00621","volume":"9","author":"C Guill\u00e9n","year":"2018","unstructured":"Guill\u00e9n, C. & Benito, M. mTORC1 overactivation as a key aging factor in the progression to type 2 diabetes mellitus. Front. Endocrinol. 9, 621 (2018).","journal-title":"Front. Endocrinol."},{"key":"95439_CR81","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell. Biol. 19, 121\u2013135 (2018).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"95439_CR82","doi-asserted-by":"publisher","first-page":"112563","DOI":"10.1016\/j.biopha.2021.112563","volume":"146","author":"M Entezari","year":"2022","unstructured":"Entezari, M. et al. N. AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation. Biomed. Pharmacother. 146, 112563 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"95439_CR83","doi-asserted-by":"crossref","unstructured":"Leonardini, A., Laviola, L., Perrini, S., Natalicchio, A. & Giorgino, F. Cross-talk between PPAR\u03b3 and insulin signaling and modulation of insulin sensitivity. PPAR Res. 818945 (2009). (2009).","DOI":"10.1155\/2009\/818945"},{"key":"95439_CR84","doi-asserted-by":"publisher","first-page":"8974","DOI":"10.3390\/ijms22168974","volume":"22","author":"C Sun","year":"2021","unstructured":"Sun, C., Mao, S., Chen, S., Zhang, W. & Liu, C. PPARs-orchestrated metabolic homeostasis in the adipose tissue. Int. J. Mol. Sci. 22, 8974 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"95439_CR85","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1152\/advan.00052.2006","volume":"30","author":"H Liang","year":"2006","unstructured":"Liang, H. & Ward, W. F. PGC-1\u03b1: a key regulator of energy metabolism. Adv. Physiol. Educ. 30, 145\u2013151 (2006).","journal-title":"Adv. Physiol. Educ."},{"key":"95439_CR86","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/antiox12051075","volume":"12","author":"SO Abu","year":"2023","unstructured":"Abu, S. O., Arroum, T., Morris, S. & Busch, K. B. PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxidants 12, 1075 (2023).","journal-title":"Antioxidants"},{"key":"95439_CR87","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41392-024-01756-w","volume":"9","author":"L Qian","year":"2023","unstructured":"Qian, L. et al. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases. Signal. Transduct. Target. Ther. 9, 50 (2023).","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95439-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95439-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95439-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:19:04Z","timestamp":1751437144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95439-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95439"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95439-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23108"}}